Net Income (TTM) Chart

Historical Net Income (TTM) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 -73.45M
March 31, 2026 -68.17M
December 31, 2025 -66.49M
September 30, 2025 -65.80M
June 30, 2025 -62.02M
March 31, 2025 -55.22M
December 31, 2024 -49.37M
September 30, 2024 -47.76M
June 30, 2024 -47.24M
March 31, 2024 -45.44M
December 31, 2023 -42.49M
September 30, 2023 -40.67M
June 30, 2023 -42.68M
March 31, 2023 -39.90M
Date Value
December 31, 2022 -39.22M
September 30, 2022 -40.61M
June 30, 2022 -34.61M
March 31, 2022 -81.92M
December 31, 2021 -82.18M
September 30, 2021 -77.59M
June 30, 2021 -80.77M
March 31, 2021 -30.52M
December 31, 2020 -29.50M
September 30, 2020 -27.72M
June 30, 2020 -27.12M
March 31, 2020 -30.38M
December 31, 2019 -34.74M

Net Income Definition

Represents net income for the period and date(s) requested in local currency by default.

Read full definition.

Net Income (TTM) Range, Past 5 Years

View Net Income (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Income (TTM) Benchmarks

View Net Income (TTM) Benchmarks
Start Trial
Viking Therapeutics, Inc. -534.80M
Capricor Therapeutics, Inc. -129.42M
Ardelyx, Inc. -55.70M
Biomea Fusion, Inc. -32.54M
ARS Pharmaceuticals, Inc. -215.43M